InnoCare
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About InnoCare
The company is a biopharmaceutical high-tech company in the commercialization stage. It was co-founded in 2015 by Dr. Cui Jisong, who has rich experience in new drug research and development and corporate management, and Academician Shi Yigong, a world-renowned structural biologist. We develop innovative drugs for patients with malignant tumors and autoimmune diseases, so that the results of innovation can benefit more patients. The company is a high-tech innovative biopharmaceutical company with excellent independent research and development capabilities as the core driving force. It has comprehensive research and development, production and commercialization capabilities, focusing on areas with huge unmet clinical needs such as tumors and autoimmune diseases, and developing first-in-class or best-in-class drugs with breakthrough potential in the global market. Main products: Orbutinib, ICP-B04, ICP-248, ICP-B02, ICP-490, ICP-B05, ICP-332, ICP-488, IL-17 small molecules, ICP-723, ICP-189, ICP-B794, etc.
How to Buy InnoCare (09969.HK)
Sign In
1-Minute Account Opening
Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.
Deposit funds
Once your account has been verified, you can deposit funds into your account using your preferred payment method.
Buy 09969.HK
Search for 09969.HK via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.